%0 Case Reports
%T Paclitaxel-Induced Cutaneous Lupus Erythematosus and Raynaud's Phenomenon.
%A Rusia K
%A Madke B
%A Kashikar Y
%A Meghe S
%J Cureus
%V 15
%N 12
%D 2023 Dec
%M 38259408
暂无%R 10.7759/cureus.50974
%X Taxanes, in combination with platinum-based drugs, are considered the initial treatment option for certain types of cancer, including ovarian cancer. Here, we report the case of a 59-year-old woman who developed a malar rash on her face, a maculopapular rash on her forearms, and bluish discoloration on her fingers immediately following the end of the third cycle of chemotherapy. After discontinuing paclitaxel and using oral and topical steroids for rash and diltiazem and topical minoxidil for the treatment of Raynaud's phenomenon, the symptoms completely resolved. While taxanes are known to cause drug-induced lupus, there has never been any information on taxanes causing isolated Raynaud's phenomenon. This is the first case report that suggests paclitaxel-induced Raynaud's phenomenon along with paclitaxel-induced lupus.